BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25550136)

  • 1. Building an outpatient cancer center pharmacy program across a tristate region.
    Skledar SJ; Doedyns A; Yourich B
    Am J Health Syst Pharm; 2015 Jan; 72(2):126-32. PubMed ID: 25550136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing pharmacists in the ambulatory care setting: Experience at the University of North Carolina Medical Center.
    Hawes EM; Misita C; Burkhart JI; McKnight L; Deyo ZM; Lee RA; Howard C; Eckel SF
    Am J Health Syst Pharm; 2016 Sep; 73(18):1425-33. PubMed ID: 27605321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specialty pharmacy for hematologic malignancies.
    Fajardo S; Zook F; Dotson E
    Am J Health Syst Pharm; 2016 Jun; 73(11):797-809. PubMed ID: 27126835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an operational productivity tool within a cancer treatment center pharmacy.
    Achey TS; Riffle AR; Rose RM; Earl M
    Am J Health Syst Pharm; 2018 Nov; 75(21):1736-1741. PubMed ID: 30282665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with a "tech-check-tech" program in an academic medical center.
    Reed M; Thomley S; Ludwig B; Rough S
    Am J Health Syst Pharm; 2011 Oct; 68(19):1820-3. PubMed ID: 21930640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and implementation of a centralized comprehensive refill authorization program in an academic health system.
    Rim MH; Thomas KC; Hatch B; Kelly M; Tyler LS
    Am J Health Syst Pharm; 2018 Feb; 75(3):132-138. PubMed ID: 29371194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a pharmacy-managed program for the transition of chemotherapy to the outpatient setting.
    McBride A; Campen CJ; Camamo J; Maloney M; Persky D; Kurtin SE; Barket NL; Krishnadasan R; Elquza E; Anwer F; Weibel K
    Am J Health Syst Pharm; 2018 May; 75(9):e246-e258. PubMed ID: 29691269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies.
    Maleki S; Alexander M; Fua T; Liu C; Rischin D; Lingaratnam S
    J Oncol Pharm Pract; 2019 Jan; 25(1):130-139. PubMed ID: 29938594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporating a clinical oncology pharmacist into an ambulatory care pharmacy in pediatric hematology-oncology and transplant clinic: Assessment and significance.
    Ali K; Al-Quteimat O; Naseem R; Malhi SM; Wajdi M; Jahan N; Ansari SH; Shamsi TS
    J Oncol Pharm Pract; 2021 Jun; 27(4):815-820. PubMed ID: 32633660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of clinical pharmacy services on patients in an outpatient chemotherapy academic clinic.
    McKee M; Frei BL; Garcia A; Fike D; Soefje SA
    J Oncol Pharm Pract; 2011 Dec; 17(4):387-94. PubMed ID: 21239453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and implementation of an interdisciplinary oncology program in a community hospital.
    Chung C; Collins A; Cui N
    Am J Health Syst Pharm; 2011 Sep; 68(18):1740-7. PubMed ID: 21880891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of an integrated ambulatory care pharmacist collaborative care workflow model in specialty clinics in a large academic health system.
    Lee J; Tong K; Stroedecke N; Monestime S; Eom E; Stutsky M; Boothe K; Luon S; Sawant V; Renauer M
    Am J Health Syst Pharm; 2023 Jun; 80(13):842-851. PubMed ID: 37144568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic?
    Ruder AD; Smith DL; Madsen MT; Kass FH
    J Oncol Pharm Pract; 2011 Dec; 17(4):425-32. PubMed ID: 21248174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of inpatient clinical pharmacy services through reallocation of pharmacists.
    Sowell AJ; Pherson EC; Almuete VI; Gillespie JV; Gilmore V; Jensen M; Nehra R; Durand KM; Nesbit TW; Swarthout MD; Efird LE
    Am J Health Syst Pharm; 2017 Nov; 74(21):1806-1813. PubMed ID: 28893729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stepwise approach to implementing ambulatory clinical pharmacy services.
    Epplen K; Dusing-Wiest M; Freedlund J; Harger N; Kathman S; Ivey MF
    Am J Health Syst Pharm; 2007 May; 64(9):945-51. PubMed ID: 17468149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision medicine in oncology: New practice models and roles for oncology pharmacists.
    Walko C; Kiel PJ; Kolesar J
    Am J Health Syst Pharm; 2016 Dec; 73(23):1935-1942. PubMed ID: 27864201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying opportunities to advance practice at a large academic medical center using the ASHP Ambulatory Care Self-Assessment Tool.
    Martirosov AL; Michael A; McCarty M; Bacon O; DiLodovico JR; Jantz A; Kostoff D; MacDonald NC; Mikulandric N; Neme K; Sulejmani N; Summers BB
    Am J Health Syst Pharm; 2018 Jul; 75(13):987-992. PubMed ID: 29844135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of a clinical pharmacist into the hematology-oncology clinics at an academic medical center.
    Valgus JM; Faso A; Gregory KM; Jarr S; Savage S; Caiola S; Walko CM; Kim J; Bernard SA
    Am J Health Syst Pharm; 2011 Apr; 68(7):613-9. PubMed ID: 21411803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding Ambulatory Care Pharmacy Residency Education Through a Multisite University-Affiliated Model.
    Schweiss SK; Westberg SM; Moon JY; Sorensen TD
    J Pharm Pract; 2017 Dec; 30(6):643-649. PubMed ID: 28110618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Certification program in antineoplastic drug preparation for pharmacy technicians and pharmacists.
    Peters BG; Wilson AL; Lunik MC; Cataldo BK
    Am J Hosp Pharm; 1994 Aug; 51(15):1902-6. PubMed ID: 7942925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.